Tracer library / [188Re]Re-ReO4
[188Re]Re-ReO4
Also written as [Re-188]ReO4
- Radionuclide
- Re-188 t½ 1020 min
- Modality
- Therapy
- Production route
- —
- Stage
- —
- Syntheses indexed
- 0
What it is
- Compound class
- perrhenate ([188Re]ReO4−), starting material for radiolabeling of monoclonal antibodies
- Target / mechanism
- —
- Clinical application
- Radiopharmaceutical therapy applications including intravascular brachytherapy for restenosis prevention, bone metastasis and synovitis pain palliation, and as a comparator for radiolabeled biomolecules PMID 22642385
- Theranostic pair
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [188Re]Re-ReO4, or handle the enquiry for you.
Get in touchNotes
Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 28951872: 'the reaction of the tetraoxo anion [188Re]ReO4− with SnCl2'.